Meghan Fitzgerald Roivant Sciences Ltd. (ROIV) insider trading activity

Meghan Fitzgerald is of Roivant Sciences Ltd.. Currently has a direct ownership of 42,963 shares of ROIV, which is worth approximately $871,719. The most recent transaction as insider was on Sep 10, 2025, when has been sold 937 shares (Common Shares) at a price of $13.77 per share, resulting in proceeds of $12,902. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43K

0% 3M change

46.25% 12M change

Total Value Held $871,719

Meghan Fitzgerald Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 10 2025	SELL Other acquisition or disposition	$12,902 $13.77 p/Share	937 Reduced 2.13%	42,963 Common Shares
Sep 10 2025	BUY Grant, award, or other acquisition	-	14,524 Added 24.86%	43,900 Common Shares
Sep 12 2024	SELL Other acquisition or disposition	$10,835 $12.12 p/Share	894 Reduced 2.95%	29,376 Common Shares
Sep 10 2024	BUY Grant, award, or other acquisition	-	16,406 Added 35.15%	30,270 Common Shares
Apr 24 2024	SELL Payment of exercise price or tax liability	$904 $10.9 p/Share	83 Reduced 0.6%	13,864 Common Shares
Apr 24 2024	BUY Grant, award, or other acquisition	-	1,261 Added 8.29%	13,947 Common Shares
Jan 19 2024	BUY Grant, award, or other acquisition	-	1,328 Added 9.48%	12,686 Common Shares

Oct 16 2023	BUY Grant, award, or other acquisition	-	1,269 Added 10.05%	11,358 Common Shares
Sep 12 2023	BUY Grant, award, or other acquisition	-	8,937 Added 46.97%	10,089 Common Shares
Jul 03 2023	BUY Grant, award, or other acquisition	-	1,152 Added 50.0%	1,152 Common Shares

Also insider at

THC

TENET HEALTHCARE CORP Healthcare